KARLEY DIONNE: Open Payments
NPI 1407632706 · PORT ST LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 66 payments from 19 companies in 2025. Trend: 2023 $125 · 2024 $1,182 · 2025 $1,933
Food & beverage: $1,319Long term medical supply or device loan: $614
| Company | Payments | Amount |
|---|---|---|
| Eko Health, Inc. | 2 | $614 |
| Lilly USA, LLC | 8 | $161 |
| Astellas Pharma US Inc | 7 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $125 |
| Novo Nordisk Inc | 7 | $121 |
| Amgen Inc. | 6 | $106 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| Exact Sciences Corporation | 3 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70 |
Products named: Veozah, Kerendia, ZEPBOUND, The Cologuard Plus Collection Kit, XIFAXAN, Ozempic, Wegovy, ACCRUFER.
Industry payments across FL — which companies pay providers there.
